Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Cytogenetically complex SEC31A-ALK fusions are recurrent in ALK-positive large B-cell lymphomas.

Literature DB >> 21109691

Cytogenetically complex SEC31A-ALK fusions are recurrent in ALK-positive large B-cell lymphomas.

Clare Bedwell, David Rowe, Deborah Moulton, Gail Jones, Nick Bown, Chris M Bacon.

Abstract

Entities: Disease Gene

Mesh：

Substances：

Year: 2010 PMID： 21109691 PMCID： PMC3031708 DOI： 10.3324/haematol.2010.031484

Source DB: PubMed Journal: Haematologica ISSN： 0390-6078 Impact factor: 9.941

× No keyword cloud information.

7 in total

1. ALK activation by the CLTC-ALK fusion is a recurrent event in large B-cell lymphoma.

Authors: Pascale De Paepe; Mathijs Baens; Han van Krieken; Bruno Verhasselt; Michel Stul; Annet Simons; Bruce Poppe; Geneviève Laureys; Paul Brons; Peter Vandenberghe; Frank Speleman; Marleen Praet; Chris De Wolf-Peeters; Peter Marynen; Iwona Wlodarska
Journal: Blood Date: 2003-05-15 Impact factor: 22.113

2. ALK-positive large B-cell lymphomas with cryptic SEC31A-ALK and NPM1-ALK fusions.

Authors: Katrien Van Roosbroeck; Jan Cools; Daan Dierickx; José Thomas; Peter Vandenberghe; Michel Stul; Jan Delabie; Chris De Wolf-Peeters; Peter Marynen; Iwona Wlodarska
Journal: Haematologica Date: 2010-03 Impact factor: 9.941

3. Fusion of the SEC31L1 and ALK genes in an inflammatory myofibroblastic tumor.

Authors: Ioannis Panagopoulos; Therese Nilsson; Henryk A Domanski; Margareth Isaksson; Pia Lindblom; Fredrik Mertens; Nils Mandahl
Journal: Int J Cancer Date: 2006-03-01 Impact factor: 7.396

Review 4. Anaplastic lymphoma kinase: role in cancer pathogenesis and small-molecule inhibitor development for therapy.

Authors: Thomas R Webb; Jake Slavish; Rani E George; A Thomas Look; Liquan Xue; Qin Jiang; Xiaoli Cui; Walter B Rentrop; Stephan W Morris
Journal: Expert Rev Anticancer Ther Date: 2009-03 Impact factor: 4.512

5. Anaplastic lymphoma kinase-positive diffuse large B-cell lymphoma: a rare clinicopathologic entity with poor prognosis.

Authors: Camille Laurent; Catherine Do; Randy D Gascoyne; Laurence Lamant; Loïc Ysebaert; Guy Laurent; Georges Delsol; Pierre Brousset
Journal: J Clin Oncol Date: 2009-07-27 Impact factor: 44.544

6. ALK-positive diffuse large B-cell lymphoma is associated with Clathrin-ALK rearrangements: report of 6 cases.

Authors: Randy D Gascoyne; Laurence Lamant; Jose I Martin-Subero; Valia S Lestou; Nancy Lee Harris; Hans-Konrad Müller-Hermelink; John F Seymour; Lynda J Campbell; Douglas E Horsman; Isabelle Auvigne; Estelle Espinos; Reiner Siebert; Georges Delsol
Journal: Blood Date: 2003-05-22 Impact factor: 22.113

7. ALK-positive plasmablastic B-cell lymphoma with expression of the NPM-ALK fusion transcript: report of 2 cases.

Authors: Mihaela Onciu; Frederick G Behm; James R Downing; Sheila A Shurtleff; Susana C Raimondi; Zhigui Ma; Stephan W Morris; Wren Kennedy; Sandra C Jones; John T Sandlund
Journal: Blood Date: 2003-06-19 Impact factor: 22.113

7 in total

12 in total

Review 1. ALK-positive large B-cell lymphoma: identification of EML4-ALK and a review of the literature focusing on the ALK immunohistochemical staining pattern.

Authors: Kana Sakamoto; Hideki Nakasone; Yuki Togashi; Seiji Sakata; Naoko Tsuyama; Satoko Baba; Akito Dobashi; Reimi Asaka; Chien-Chen Tsai; Shih-Sung Chuang; Koji Izutsu; Yoshinobu Kanda; Kengo Takeuchi
Journal: Int J Hematol Date: 2016-01-18 Impact factor: 2.490

Review 2. ALK-immunoreactive neoplasms.

Authors: Parham Minoo; Huan-You Wang
Journal: Int J Clin Exp Pathol Date: 2012-05-23

Review 3. Targeting ALK: Precision Medicine Takes on Drug Resistance.

Authors: Jessica J Lin; Gregory J Riely; Alice T Shaw
Journal: Cancer Discov Date: 2017-01-25 Impact factor: 39.397

4. Promising response of anaplastic lymphoma kinase-positive large B-cell lymphoma to crizotinib salvage treatment: case report and review of literature.

Authors: Jian Li; Jian Ouyang; Rongfu Zhou; Bing Chen; Yong Xu
Journal: Int J Clin Exp Med Date: 2015-05-15

Review 5. The histological and biological spectrum of diffuse large B-cell lymphoma in the World Health Organization classification.

Authors: Madhu P Menon; Stefania Pittaluga; Elaine S Jaffe
Journal: Cancer J Date: 2012 Sep-Oct Impact factor: 3.360